PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells

In recent years, immunotherapies, such as those involving chimeric antigen receptor (CAR) T cells, have become increasingly promising approaches to non-small-cell lung cancer (NSCLC) treatment. In this study, we explored the antitumor potential of prostate stem cell antigen (PSCA)-redirected CAR T a...

Full description

Bibliographic Details
Main Authors: Xinru Wei, Yunxin Lai, Jin Li, Le Qin, Youdi Xu, Ruocong Zhao, Baiheng Li, Simiao Lin, Suna Wang, Qiting Wu, Qiubin Liang, Muyun Peng, Fenglei Yu, Yangqiu Li, Xuchao Zhang, Yilong Wu, Pentao Liu, Duanqing Pei, Yao Yao, Peng Li
Format: Article
Language:English
Published: Taylor & Francis Group 2017-03-01
Series:OncoImmunology
Subjects:
car t
muc1
non-small-cell lung cancer
patient-derived xenograft
psca
Online Access:http://dx.doi.org/10.1080/2162402X.2017.1284722

Internet

http://dx.doi.org/10.1080/2162402X.2017.1284722

Similar Items